In-vivo Efficacy of Patient Preoperative Prep

NCT02831998 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2023-02-08

Study results available
· View outcomes & findings →

Summary

The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.

Conditions

  • Surgical Skin Preparation

Interventions

DRUG

ZuraPrep

Apply topically.

DRUG

ChloraPrep

Apply topically.

DRUG

ZP Vehicle

Apply topically.

Sponsors & Collaborators

  • Zurex Pharma, Inc.

    lead INDUSTRY

Principal Investigators

  • Muhammad H Bashir · Microbac Laboratories, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-27
Primary Completion
2017-04-09
Completion
2017-04-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02831998 on ClinicalTrials.gov